YIPF5 is integral to vesicular trafficking:
ER-Golgi Transport: Facilitates cargo shuttling between the ER and Golgi, critical for secretory pathway efficiency .
Prohormone Processing: In pancreatic beta cells, YIPF5 ensures proper transport of proinsulin to the Golgi for maturation .
Golgi Structure Maintenance: Depletion disrupts Golgi integrity, underscoring its structural role .
Recombinant YIPF5 is typically expressed in eukaryotic systems (e.g., HEK293 or insect cells) to ensure proper folding and post-translational modifications. Key steps include:
Vector Design: Codon-optimized for X. laevis expression.
Affinity Chromatography: Tags (e.g., His-tag) enable purification via nickel or glutathione columns .
Quality Control: Validated via SDS-PAGE, Western blot (using antibodies like Proteintech 12931-1-AP), and mass spectrometry .
Multiple antibodies against YIPF5 are available, supporting diverse experimental workflows:
| Antibody | Host | Applications | Reactivity |
|---|---|---|---|
| Proteintech 12931-1-AP | Rabbit | WB, IHC, ELISA | Human, Mouse, Rat |
| ABIN653506 | Rabbit | WB, IHC (paraffin) | Human, Mouse |
| Thermo Fisher PA5-67301 | Rabbit | IF, IP | Broad cross-species (91% mouse identity) |
Xenopus Egg Proteomics: A landmark study identified >11,000 proteins in X. laevis eggs, establishing YIPF5 as part of the secretory machinery .
Concentration Estimation: Quantitative proteomics estimated YIPF5 at ~30 nM in eggs, correlating with its role in high-throughput trafficking .
RNA-Binding Partners: In X. laevis egg extracts, YIPF5-associated transcripts encode proteins involved in cell adhesion and membrane dynamics, suggesting regulatory cross-talk .
Disease Links: Human orthologs of YIPF5 are implicated in congenital disorders of glycosylation and diabetes due to ER-Golgi trafficking defects .
KEGG: xla:380087
UniGene: Xl.63896
Xenopus laevis offers several significant advantages as a model organism for protein studies:
Ease of obtaining and maintaining cultures: Xenopus neural tubes and retinal ganglion cells can be obtained approximately one day after fertilization, which is considerably faster than other model systems like chicken (6 days) or rodent (16-18 days) embryos .
Large growth cones: Xenopus laevis neurons extend growth cones 10-30 μm in diameter, significantly larger than those from rat hippocampal neurons (5-10 μm) or chicken embryos. This size advantage makes them ideal for studying cytoskeletal dynamics .
Sequenced genome: The Xenopus genome has been sequenced, allowing for gene expression modifications through exogenous molecules .
Low maintenance requirements: Xenopus cell cultures do not require special culture conditions and are suitable for long periods of live imaging .
Recombinant Xenopus laevis YIPF5 protein is produced in an E. coli expression system and contains an N-terminal His tag, which distinguishes it from the native protein. This recombinant version is engineered to include the full-length protein (amino acids 1-256) while maintaining high purity (greater than 90% as determined by SDS-PAGE). The addition of the His tag facilitates protein purification and detection in experimental settings but may slightly alter the protein's properties compared to its native form .
Recombinant YIPF5 protein requires careful handling to maintain its structural integrity and activity. The optimal storage and reconstitution conditions are:
Storage Conditions:
Store at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
The protein is stored in Tris/PBS-based buffer with 6% Trehalose at pH 8.0
Reconstitution Protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C
When incorporating YIPF5 in Xenopus laevis cytoskeletal studies, researchers should consider the following methodological approach:
Culturing System Selection: Utilize Xenopus laevis neural tube explants (from stage 20 embryos) or retinal ganglion cells (from stage 28 embryos) for cytoskeletal dynamics studies, as these provide optimally sized growth cones for imaging .
Imaging Optimization: Take advantage of the relatively large growth cones (10-30 μm in diameter) for high-resolution imaging of cytoskeletal components. This is particularly important when studying potential interactions between YIPF5 and cytoskeletal elements .
Experimental Design Considerations:
For live imaging experiments, maintain cultures in simple media without special conditions
Design experiments that can leverage the robust nature of Xenopus cultures, which can be maintained for long periods of live imaging
Consider the role of YIPF5 in membrane trafficking when designing experiments involving growth cone dynamics or axon pathfinding
Protein Delivery Methods:
Microinjection of mRNA encoding tagged YIPF5 variants
Application of recombinant YIPF5 protein to cultures
Gene expression modification through CRISPR/Cas9 or morpholinos
Researchers working with recombinant YIPF5 should be prepared to address several technical challenges:
Protein Stability Issues:
Experimental Validation:
Confirming that the His-tagged recombinant protein maintains native functionality
Ensuring that the E. coli-expressed protein has proper folding and post-translational modifications
Distinguishing between effects of the recombinant protein and endogenous YIPF5
Species-Specific Considerations:
Reference Database Challenges:
While the specific role of YIPF5 in axon pathfinding has not been fully characterized in the provided search results, we can hypothesize its potential contributions based on Xenopus laevis growth cone studies:
Axon pathfinding in Xenopus laevis involves complex cytoskeletal dynamics that regulate growth cone adhesion, extension, and guidance. YIPF5, as a membrane protein, may participate in several key processes:
Membrane Trafficking Regulation: YIPF5 may modulate the delivery of adhesion molecules or receptors to the growth cone membrane, which is critical for proper axon guidance. In Xenopus, point contacts bind growth cones to extracellular matrix (ECM) and are essential for neurite growth and dynamics .
Cytoskeletal Interaction: Through its potential interaction with cytoskeletal components, YIPF5 might influence F-actin dynamics or microtubule organization in growth cones. Research has shown that in Xenopus laevis, coordinated Rho GTPase activity is necessary for generating point contacts that stimulate neurite growth .
Vesicle Transport: YIPF5 may facilitate the transport of vesicles containing guidance cue receptors or adhesion molecules along microtubules in the growth cone. The relatively large size of Xenopus growth cones (10-30 μm) makes them ideal for studying such processes .
ECM Remodeling: YIPF5 could potentially be involved in regulating proteins that remodel the ECM. Studies have shown that Xenopus growth cones extend F-actin-rich invadosomes containing metalloproteinases to promote ECM remodeling and proper axon extension .
For studying YIPF5 interactions in Xenopus laevis, researchers should implement comprehensive proteomics strategies that overcome the challenges inherent to non-model organisms:
Reference Database Development:
Sample Preparation Optimization:
Quantitative Approaches:
Data Analysis Considerations:
Evolutionary conservation analysis of YIPF5 can provide valuable insights for functional studies through several approaches:
Cross-Species Comparison:
Compare YIPF5 sequences across different model organisms to identify highly conserved domains
The number of peptides identified decreases with evolutionary distance, reflecting fewer exactly matched peptides
Focus functional studies on regions that show high conservation, as these likely represent critical functional domains
Homolog Identification:
Domain Analysis:
Analyze the conservation of specific protein domains across species
Determine if the transmembrane regions and other structural features of YIPF5 are preserved
Predict functional importance based on evolutionary pressure to maintain specific structural elements
Reference Set Development:
When working with recombinant YIPF5, researchers may encounter several sources of experimental variability that should be carefully controlled:
Protein Stability and Activity:
Variability Source: Loss of protein activity due to improper storage or reconstitution
Solution: Strictly adhere to recommended storage conditions (-20°C/-80°C); avoid repeated freeze-thaw cycles; reconstitute protein immediately before use; add glycerol (final concentration 50%) for long-term storage
Batch-to-Batch Variation:
Experimental Design Inconsistencies:
Imaging Variability:
Proteomics Data Variation:
To effectively analyze YIPF5 localization and function in Xenopus laevis neurons, researchers should implement a multi-faceted approach:
High-Resolution Imaging Techniques:
Co-localization Studies:
Functional Perturbation Approaches:
Design loss-of-function experiments using morpholinos or CRISPR/Cas9
Implement gain-of-function studies with overexpression of wild-type or mutant YIPF5
Create domain-specific mutations to map functional regions of the protein
Quantitative Analysis Methods:
Measure growth cone morphology parameters (area, perimeter, filopodia number)
Analyze axon outgrowth rates and guidance responses
Quantify cytoskeletal dynamics parameters in the presence/absence of functional YIPF5
Proteomic Validation:
Research on YIPF5 may yield contradictory results due to several factors:
Reference Database Discrepancies:
Contradiction Source: Different protein identification results depending on the reference database used
Resolution: Utilize the most comprehensive reference set available; combine PHROG (which identifies ~10% more peptides than preliminary gene models) with gene models for maximum coverage; document the specific database used in all publications
Model System Variations:
Protein Tag Interference:
Developmental Stage Differences:
Contradiction Source: YIPF5 function may vary across developmental stages
Resolution: Clearly document the specific developmental stages used (e.g., stage 28 for retinal ganglion cells, stage 20 for neural tube explants); conduct stage-specific analyses; avoid generalizing findings across all developmental periods
Methodology Variation:
Several emerging technologies hold promise for advancing YIPF5 research in Xenopus laevis:
CRISPR/Cas9 Gene Editing:
Application: Generate YIPF5 knockout or knock-in Xenopus models
Advantage: Allows precise genetic manipulation to study loss-of-function or introduce specific mutations
Implementation: Design guide RNAs targeting YIPF5; inject into early-stage embryos; validate editing efficiency
Advanced Proteomics Approaches:
Super-Resolution Microscopy:
Application: Visualize YIPF5 localization and dynamics at nanoscale resolution
Advantage: Leverages the relatively large size of Xenopus growth cones (10-30 μm) for detailed imaging
Implementation: Apply techniques such as STED, PALM, or STORM to visualize YIPF5 in relation to cytoskeletal components
Optogenetic Tools:
Application: Spatiotemporally control YIPF5 function in living neurons
Advantage: Allows precise manipulation of protein activity during specific phases of axon guidance
Implementation: Develop light-sensitive YIPF5 variants; express in Xenopus neurons; manipulate with targeted light stimulation
Improved Bioinformatics Approaches:
Research on YIPF5 in Xenopus laevis can provide valuable insights into human development and disease through several translational pathways:
Evolutionary Conservation:
Neurodevelopmental Disorders:
If YIPF5 plays a role in axon pathfinding or neuronal development in Xenopus, it may have implications for human neurodevelopmental disorders
The relatively simple nervous system of Xenopus tadpoles allows for clear observation of neuronal pathfinding defects
Findings could inform research on conditions involving aberrant axon guidance
Cell Biological Mechanisms:
YIPF5's potential role in membrane trafficking or cytoskeletal regulation may have broad implications
Understanding these fundamental processes in Xenopus can elucidate similar mechanisms in human cells
Such insights could inform research on diseases involving membrane dysfunction or cytoskeletal abnormalities
Method Development:
Drug Target Identification:
If YIPF5 is identified as a critical regulator of specific developmental processes, it could represent a potential drug target
Xenopus models allow for cost-effective screening of compounds that modulate YIPF5 function
Promising compounds could then be tested in mammalian models before clinical translation